Opioid Induced Constipation Drugs Market Report

Global and Region Opioid Induced Constipation Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：207
  • REPORT CODE：GMM960417
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Opioid Induced Constipation Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Opioid Induced Constipation Drugsmarket, defines the market attractiveness level of Opioid Induced Constipation Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Opioid Induced Constipation Drugs industry, describes the types of Opioid Induced Constipation Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Opioid Induced Constipation Drugs market and the development prospects and opportunities of Opioid Induced Constipation Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Opioid Induced Constipation Drugs market in Chapter 13.

    By Player:

    • Mallinckrodt Pharmaceuticals

    • Pfizer

    • Ironwood Pharmaceutical Inc

    • Shionogi & Co Ltd

    • Progenics Pharmaceuticals Inc

    • Merck & Co Inc

    • AstraZeneca plc

    • Nektar Therapeutics

    • Purdue Pharma

    • Salix Pharmaceuticals Inc

    By Type:

    • Lubiprostone

    • Methyl Naltrexone Bromide

    • Naldemedine

    • Alvimopan

    • Other

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Opioid Induced Constipation Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Opioid Induced Constipation Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Opioid Induced Constipation Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Opioid Induced Constipation Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Opioid Induced Constipation Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Opioid Induced Constipation Drugs Consumption (2017-2022)

    • 7.2 United States Opioid Induced Constipation Drugs Consumption (2017-2022)

    • 7.3 Europe Opioid Induced Constipation Drugs Consumption (2017-2022)

    • 7.4 China Opioid Induced Constipation Drugs Consumption (2017-2022)

    • 7.5 Japan Opioid Induced Constipation Drugs Consumption (2017-2022)

    • 7.6 India Opioid Induced Constipation Drugs Consumption (2017-2022)

    • 7.7 South Korea Opioid Induced Constipation Drugs Consumption (2017-2022)

    8 Region and Country-wise Opioid Induced Constipation Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Opioid Induced Constipation Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Opioid Induced Constipation Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Opioid Induced Constipation Drugs Consumption Forecast (2022-2028)

    • 8.4 China Opioid Induced Constipation Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Opioid Induced Constipation Drugs Consumption Forecast (2022-2028)

    • 8.6 India Opioid Induced Constipation Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Opioid Induced Constipation Drugs Consumption Forecast (2022-2028)

    9 Global Opioid Induced Constipation Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Opioid Induced Constipation Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Lubiprostone Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Methyl Naltrexone Bromide Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Naldemedine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Alvimopan Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Opioid Induced Constipation Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Opioid Induced Constipation Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Opioid Induced Constipation Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Methyl Naltrexone Bromide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Naldemedine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Alvimopan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Opioid Induced Constipation Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Opioid Induced Constipation Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Opioid Induced Constipation Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Opioid Induced Constipation Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Opioid Induced Constipation Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Opioid Induced Constipation Drugs Market Competitive Analysis

    • 14.1 Mallinckrodt Pharmaceuticals

      • 14.1.1 Mallinckrodt Pharmaceuticals Company Details

      • 14.1.2 Mallinckrodt Pharmaceuticals Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Mallinckrodt Pharmaceuticals Opioid Induced Constipation Drugs Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Opioid Induced Constipation Drugs Product and Service

    • 14.3 Ironwood Pharmaceutical Inc

      • 14.3.1 Ironwood Pharmaceutical Inc Company Details

      • 14.3.2 Ironwood Pharmaceutical Inc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Ironwood Pharmaceutical Inc Opioid Induced Constipation Drugs Product and Service

    • 14.4 Shionogi & Co Ltd

      • 14.4.1 Shionogi & Co Ltd Company Details

      • 14.4.2 Shionogi & Co Ltd Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Shionogi & Co Ltd Opioid Induced Constipation Drugs Product and Service

    • 14.5 Progenics Pharmaceuticals Inc

      • 14.5.1 Progenics Pharmaceuticals Inc Company Details

      • 14.5.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Service

    • 14.6 Merck & Co Inc

      • 14.6.1 Merck & Co Inc Company Details

      • 14.6.2 Merck & Co Inc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck & Co Inc Opioid Induced Constipation Drugs Product and Service

    • 14.7 AstraZeneca plc

      • 14.7.1 AstraZeneca plc Company Details

      • 14.7.2 AstraZeneca plc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AstraZeneca plc Opioid Induced Constipation Drugs Product and Service

    • 14.8 Nektar Therapeutics

      • 14.8.1 Nektar Therapeutics Company Details

      • 14.8.2 Nektar Therapeutics Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Nektar Therapeutics Opioid Induced Constipation Drugs Product and Service

    • 14.9 Purdue Pharma

      • 14.9.1 Purdue Pharma Company Details

      • 14.9.2 Purdue Pharma Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Purdue Pharma Opioid Induced Constipation Drugs Product and Service

    • 14.10 Salix Pharmaceuticals Inc

      • 14.10.1 Salix Pharmaceuticals Inc Company Details

      • 14.10.2 Salix Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Salix Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Opioid Induced Constipation Drugs

    • Figure Opioid Induced Constipation Drugs Picture

    • Table Global Opioid Induced Constipation Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Opioid Induced Constipation Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Opioid Induced Constipation Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Opioid Induced Constipation Drugs Consumption by Country (2017-2022)

    • Figure United States Opioid Induced Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Opioid Induced Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Opioid Induced Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Opioid Induced Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Opioid Induced Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Opioid Induced Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Opioid Induced Constipation Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Opioid Induced Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Opioid Induced Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Opioid Induced Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Opioid Induced Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Opioid Induced Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Opioid Induced Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lubiprostone Consumption and Growth Rate (2017-2022)

    • Figure Global Methyl Naltrexone Bromide Consumption and Growth Rate (2017-2022)

    • Figure Global Naldemedine Consumption and Growth Rate (2017-2022)

    • Figure Global Alvimopan Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Methyl Naltrexone Bromide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Naldemedine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alvimopan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Opioid Induced Constipation Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Opioid Induced Constipation Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Mallinckrodt Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Mallinckrodt Pharmaceuticals Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Pharmaceuticals Opioid Induced Constipation Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Opioid Induced Constipation Drugs Product and Service

    • Table Ironwood Pharmaceutical Inc (Foundation Year, Company Profile and etc.)

    • Table Ironwood Pharmaceutical Inc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ironwood Pharmaceutical Inc Opioid Induced Constipation Drugs Product and Service

    • Table Shionogi & Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Shionogi & Co Ltd Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shionogi & Co Ltd Opioid Induced Constipation Drugs Product and Service

    • Table Progenics Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Service

    • Table Merck & Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Opioid Induced Constipation Drugs Product and Service

    • Table AstraZeneca plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca plc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc Opioid Induced Constipation Drugs Product and Service

    • Table Nektar Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Nektar Therapeutics Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nektar Therapeutics Opioid Induced Constipation Drugs Product and Service

    • Table Purdue Pharma (Foundation Year, Company Profile and etc.)

    • Table Purdue Pharma Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Pharma Opioid Induced Constipation Drugs Product and Service

    • Table Salix Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Salix Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US